Vivesto AB OASMY Stock
Vivesto AB Price Chart
Vivesto AB OASMY Financial and Trading Overview
| Vivesto AB stock price | 0.0001 USD |
| Previous Close | 0.0001 USD |
| Open | 0.05 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.05 - 0.05 USD |
| 52 Week Range | 0.0001 - 0.05 USD |
| Volume | 1.7K USD |
| Avg. Volume | 18 USD |
| Market Cap | 36.9K USD |
| Beta (5Y Monthly) | 0.823 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.02 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | January 28, 2026 |
| 1y Target Est | N/A |
OASMY Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.0004032258 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Vivesto AB Stock Price History
| Beta (5Y Monthly) | 0.823 |
| 52-Week Change | -99.50% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 0.05 USD |
| 52 Week Low | 0.0001 USD |
| 50-Day Moving Average | 0.0001 USD |
| 200-Day Moving Average | 0.0092565 USD |
OASMY Share Statistics
| Avg. Volume (3 month) | 18 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 369.05M |
| Float | 311.42M |
| Short Ratio | 0.03 |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | 63.73K |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0.010% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | December 31, 2025 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -13.34% |
| Return on Equity (ttm) | -24.093% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -32584000 USD |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | 10.44 USD |
| Current Ratio (mrq) | 0.225 |
| Book Value Per Share (mrq) | 0.248 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | -30752876 USD |
Profile of Vivesto AB
| Country | United States |
| State | N/A |
| City | Solna |
| Address | Gustav III:s Boulevard 46 |
| ZIP | 169 73 |
| Phone | 46 18 50 54 40 |
| Website | https://www.vivesto.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 4 |
Vivesto AB develops, develops, markets, and sells drugs in the field of human and veterinary oncology in Sweden. Its lead product, Paccal Vet, is a formulation of paclitaxel with its XR-17 encapsulation technology for the treatment of canine mastocytoma. The company also offers Apealea, an injectable formulation of paclitaxel for the treatment of various cancers. In addition, it develops Cantrixil, a drug candidate for the treatment of advanced cancer, and Docetaxel micellar for the treatment of prostate cancer. The company was formerly known as Oasmia Pharmaceutical AB (publ) and changed its name to Vivesto AB in March 2022. Vivesto AB was founded in 1988 and is headquartered in Solna, Sweden.
Q&A For Vivesto AB Stock
What is a current OASMY stock price?
Vivesto AB OASMY stock price today per share is 0.0001 USD.
How to purchase Vivesto AB stock?
You can buy OASMY shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Vivesto AB?
The stock symbol or ticker of Vivesto AB is OASMY.
Which industry does the Vivesto AB company belong to?
The Vivesto AB industry is Drug Manufacturers - Specialty & Generic.
How many shares does Vivesto AB have in circulation?
The max supply of Vivesto AB shares is 369.04M.
What is Vivesto AB Price to Earnings Ratio (PE Ratio)?
Vivesto AB PE Ratio is now.
What was Vivesto AB earnings per share over the trailing 12 months (TTM)?
Vivesto AB EPS is -0.02 USD over the trailing 12 months.
Which sector does the Vivesto AB company belong to?
The Vivesto AB sector is Healthcare.